Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
53.72
-0.96 (-1.76%)
Mar 20, 2026, 4:00 PM EDT - Market closed

Inspire Medical Systems Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
104.81150.15185.54441.59214.47
Short-Term Investments
203.46295.4274.849.82-
Cash & Short-Term Investments
308.27445.55460.38451.41214.47
Cash Growth
-30.81%-3.22%1.98%110.48%-8.49%
Accounts Receivable
--89.8861.2334.18
Inventory
145.2980.1233.8911.8917.23
Other Current Assets
10.412.079.65.512.66
Total Current Assets
583.65630.81593.74530.03268.54
Net Property, Plant & Equipment
121.495.2462.6524.1316.41
Long-Term Investments
96.33719.14-9.94
Other Long-Term Assets
105.9311.3411.2810.720.2
Total Assets
907.32808.38676.81564.88295.08
Accounts Payable
--38.8426.8511.67
Accrued Expenses
--39.2734.3420.45
Current Portion of Long-Term Debt
----9.19
Total Current Liabilities
96.0688.578.1161.1941.31
Long-Term Debt
----15.8
Long-Term Leases
3030.0424.857.548.8
Other Long-Term Liabilities
0.10.151.350.150.13
Total Long-Term Liabilities
30.130.1926.197.6824.73
Total Liabilities
126.16118.69104.368.8766.04
Common Stock
0.030.030.030.030.03
Additional Paid-in Capital
927.16981.04917.11820.34508.47
Accumulated Other Comprehensive Income
0.460.540.8-0.09-0.06
Retained Earnings
-146.49-291.91-345.42-324.27-279.39
Shareholders' Equity
781.16689.7572.51496.01229.05
Total Liabilities & Equity
907.32808.38676.81564.88295.08
Total Debt
3030.0424.857.5433.78
Net Cash (Debt)
278.27415.51435.53443.88180.68
Net Cash Growth
-33.03%-4.60%-1.88%145.66%-11.31%
Net Cash Per Share
9.3513.6014.8615.816.63
Book Value
781.16689.7572.51496.01229.05
Book Value Per Share
26.2522.5819.5417.678.40
Tangible Book Value
781.16689.7572.51496.01229.05
Tangible Book Value Per Share
26.2522.5819.5417.678.40
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q